Overbrook Management Corp Cuts Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Overbrook Management Corp cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 73,283 shares of the company’s stock after selling 261 shares during the quarter. HealthEquity accounts for approximately 1.5% of Overbrook Management Corp’s investment portfolio, making the stock its 26th largest position. Overbrook Management Corp owned 0.08% of HealthEquity worth $7,032,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Paladin Wealth LLC purchased a new stake in HealthEquity during the third quarter valued at approximately $39,000. UMB Bank n.a. lifted its position in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in HealthEquity during the second quarter worth $73,000. GAMMA Investing LLC increased its position in HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after acquiring an additional 344 shares during the last quarter. Finally, Quarry LP raised its stake in shares of HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 2.3 %

Shares of HealthEquity stock opened at $102.42 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market cap of $8.88 billion, a price-to-earnings ratio of 93.96, a PEG ratio of 1.77 and a beta of 0.54. The firm’s 50-day moving average is $98.90 and its two-hundred day moving average is $86.63. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $105.82.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Bank of America boosted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Royal Bank of Canada increased their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. Finally, JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $110.71.

Insider Activity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,289 shares of company stock worth $3,355,718. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.